ClariVest Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-24,422
| Closed | -$1.29M | – | 854 |
|
|
2020
Q3 | $1.29M | Sell |
24,422
-1,038
| -4% | -$54.8K | 0.04% | 278 |
|
|
2020
Q2 | $1.56M | Sell |
25,460
-1,013
| -4% | -$62.1K | 0.04% | 265 |
|
|
2020
Q1 | $1.5M | Sell |
26,473
-460
| -2% | -$26K | 0.04% | 236 |
|
|
2019
Q4 | $1.53M | Sell |
26,933
-11,924
| -31% | -$679K | 0.04% | 283 |
|
|
2019
Q3 | $2.08M | Sell |
38,857
-300
| -0.8% | -$16.1K | 0.05% | 252 |
|
|
2019
Q2 | $2.34M | Sell |
39,157
-493
| -1% | -$29.4K | 0.05% | 234 |
|
|
2019
Q1 | $2.47M | Sell |
39,650
-1,615
| -4% | -$101K | 0.05% | 294 |
|
|
2018
Q4 | $2.5M | Buy |
41,265
+11,433
| +38% | +$693K | 0.05% | 264 |
|
|
2018
Q3 | $1.75M | Sell |
29,832
-1,214
| -4% | -$71K | 0.03% | 343 |
|
|
2018
Q2 | $1.39M | Sell |
31,046
-607
| -2% | -$27.3K | 0.02% | 399 |
|
|
2018
Q1 | $1.4M | Buy |
31,653
+300
| +1% | +$13.3K | 0.02% | 381 |
|
|
2017
Q4 | $1.36M | Buy |
31,353
+6,580
| +27% | +$285K | 0.02% | 387 |
|
|
2017
Q3 | $1.15M | Buy |
24,773
+100
| +0.4% | +$4.65K | 0.03% | 332 |
|
|
2017
Q2 | $1.22M | Sell |
24,673
-9
| -0% | -$446 | 0.03% | 323 |
|
|
2017
Q1 | $1.35M | Buy |
24,682
+14,175
| +135% | +$777K | 0.03% | 315 |
|
|
2016
Q4 | $585K | Buy |
10,507
+2,100
| +25% | +$117K | 0.02% | 389 |
|
|
2016
Q3 | $384K | Buy |
8,407
+100
| +1% | +$4.57K | 0.01% | 416 |
|
|
2016
Q2 | $332K | Buy |
8,307
+400
| +5% | +$16K | 0.01% | 410 |
|
|
2016
Q1 | $275K | Buy |
7,907
+100
| +1% | +$3.48K | 0.01% | 424 |
|
|
2015
Q4 | $336K | Buy |
7,807
+1,500
| +24% | +$64.6K | 0.01% | 393 |
|
|
2015
Q3 | $274K | Hold |
6,307
| – | – | 0.01% | 381 |
|
|
2015
Q2 | $325K | Buy |
6,307
+100
| +2% | +$5.15K | 0.01% | 364 |
|
|
2015
Q1 | $242K | Hold |
6,207
| – | – | 0.01% | 386 |
|
|
2014
Q4 | $239K | Buy |
6,207
+207
| +3% | +$7.97K | 0.01% | 324 |
|
|
2014
Q3 | $212K | Buy |
+6,000
| New | +$212K | 0.01% | 358 |
|